INCONTINENCE CONTROL SYSTEM (INTERSTIM®) FOR THE FECAL INCONTINENCE TREATMENT AT HEALTHCARE PUBLIC SECTOR IN MEXICO
Author(s)
Cerezo O1, Orozco D2, Saracho A2, Lemus F2, Flores B2, Valencia J3, Figueroa A2
1Medtronic, MX, Mexico, 2Pharmamanagement EAS S de RL de CV, Cuidad de México, Mexico, 3Medtronic, Miami, FL, USA
OBJECTIVES:: The social impact of fecal incontinence (FI) could be devastating, that's the reason why FI could decrease QoL and trigger emotional issues. At the same time FI causes economic problems for the healthcare sector. Nowadays the Mexican clinical practice recommends graciloplasty for those patients who have failed to esfinteroplasty. In this sense, to demonstrate the suitability and the value for money of new alternatives, we designed and executed a full economic evaluation to assess the Incontinence Control System (Interstim®) for the treatment of fecal incontinence vs SoC available at healthcare public sector in Mexico.
Conference/Value in Health Info
2017-09, ISPOR Latin America 2017, Sao Paulo, Brazil
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PMD29
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Gastrointestinal Disorders, Multiple Diseases
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now